The Dales Report - Benzinga

SPY764.34−0.65%QQQ703.56−1.65%BTC/USD78,550.40−3.32%DIA522.70−0.01%GLD367.57−0.27%TLT81.70+0.26%

Premium Services

Articles by The Dales Report

Boris Jordan's Cannabis Insights: Rescheduling Update

Boris Jordan's Cannabis Insights: Rescheduling Update

The TDR Three Key Takeaways on Rescheduling Talk with Boris Jordan & $CBST & $VRNOF Announcement

TDR Exclusive: Republican And Democrat Senators' Views On SAFE Banking And Rescheduling

TDR Exclusive: Republican And Democrat Senators' Views On SAFE Banking And Rescheduling

The TDR Three Key Takeaways on the SAFE Banking Act: TDR’s Shadd Dales has live interviews in Washington DC with senators on their views of the SAFE Banking Act Senators believe economic and safety benefits underscore the urgent need for the SAFE Banking Act.

Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss

Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss

The TDR Three Key Takeaways:

Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application

Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application

Three Key Takeaways:

MAPS, Eight Capital And Integrated V.C. Backs Numinus $6M Offering

MAPS, Eight Capital And Integrated V.C. Backs Numinus $6M Offering

The TDR Three Takeaways:

EU Allocates €6.5M To Study Psychedelics For Pulmonary Disorder, Multiple Sclerosis, ALS, Parkinson's

EU Allocates €6.5M To Study Psychedelics For Pulmonary Disorder, Multiple Sclerosis, ALS, Parkinson's

This article was originally published on The Dales Report and appears here with permission.

Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation

Awakn Life Sciences Enters Into Global Licensing Agreement For Sublingual Delivery Formulation

Awakn Life Sciences (OTC: AWKNF), a clinical-stage biotechnology company specializing in the development of ketamine-assisted treatments for addiction, has enter

Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate

Numinus Reports Q4 & Full Year Fiscal 2023 Results, Including Greatly Reduced Cash Burn Rate

Psychedelic therapy clinic provider Numinus Wellness (TSX:NUMI) (OTC: NUMIF) announced

5 Scientifically Proven Truisms About The Amazing Pharmacological Effects Of Psilocybin

5 Scientifically Proven Truisms About The Amazing Pharmacological Effects Of Psilocybin

In the realm of contemporary science and healthcare, there exists an increasingly fervent excitement centered around an unassuming fungus that has captivated the imagination of researchers, clinicians, and the curious alike.

10-Year Treasuries Exceed 5% For First Time Since 2007, Then Crater On Ackman Short Cover

10-Year Treasuries Exceed 5% For First Time Since 2007, Then Crater On Ackman Short Cover

A milestone of sorts was achieved in the U.S. Treasury market on Monday, as the yield on the 10-year Treasury Note exceeded 5% for the first time in 16 years. This rate, widely recognized on Wall Street as a pivotal gauge of the note’s market’s stability, poked above a key psychological level with traders.

Payton Nyquvest On Off-Label Markets

Payton Nyquvest On Off-Label Markets

In this episode of The Dales Report, we’re sitting down with Numinus Wellness CEO Payton Nyquvest for a psychedelic exclusive. Our topic of conversation with Payton today steers into the recent FDA warning and the dynamic world of off-label markets for new compounds.

Pelorus Capital Group's Rob Sechrist Talks Cannabis, Cory Gardner And Steve Daines

Pelorus Capital Group's Rob Sechrist Talks Cannabis, Cory Gardner And Steve Daines

We’re back with another Canna Exclusive. In this episode of The Dales Report, we’re joined by a very special guest – and one you’re probably familiar with if you tune in regularly – the President and Co-manager of Pelorus Venture Capital, Rob Sechrist.

Esteemed Psychedelic Researcher And Pioneer Roland Griffiths Passes Away At Age 77

Esteemed Psychedelic Researcher And Pioneer Roland Griffiths Passes Away At Age 77

A sad day in the psychedelics community today as news filters out that leading industry neuroscientist, Dr. Roland Griffiths, Ph.D., has passed.

MariMed Sets Up Shop In Illinois Town Known For Guinness World Record-Holding Attractions

MariMed Sets Up Shop In Illinois Town Known For Guinness World Record-Holding Attractions

MariMed Inc. (OTC: MRMD) retail footprint has once again expanded, as the company officially unveiled an adult-use Thrive dispensary in Casey, Illinois

Joe Caltabiano On Preparation For Legal Psychedelics

Joe Caltabiano On Preparation For Legal Psychedelics

In this episode of The Dales Report, we’re back with another Psychedelic Exclusive. This podcast, we speak with Joe Caltabiano, chairman of Healing CREI and Founder of JSC Fund. Joe is well known as a public speaker and contributor to media such as Vice and Bloomberg, and he’s a big philanthropist in cancer research and support.

Pelorus Capital Group Managing Partner Rob Sechrist And Former US Senator Cory Gardner Comments On SAFER Banking At Benzinga

Pelorus Capital Group Managing Partner Rob Sechrist And Former US Senator Cory Gardner Comments On SAFER Banking At Benzinga

We’re back with another Cannabis Exclusive. In this episode on The Dales Report, we sat down with both former US Senator Cory Gardner and President of Pelorus Equity Group, Rob Sechrist, at the Benzinga Cannabis Capital Conference in Chicago this past Wednesday.

SAFER Banking Trajectory In Question As Republican Leader Kevin McCarthy Ousted As House Speaker

SAFER Banking Trajectory In Question As Republican Leader Kevin McCarthy Ousted As House Speaker

Following the successful Senate Banking Committee markup vote last week, the prospects for bicameral SAFER Banking Act legislation appeared positive in both legislative branches of government.

'Star Studded' Benzinga Cannabis Capital Conference Arrives At A Time Where Critical Reform In On The Horizon

'Star Studded' Benzinga Cannabis Capital Conference Arrives At A Time Where Critical Reform In On The Horizon

A lot of news action could happen in cannabis this week, between actions in Washington DC, and Benzinga’s Cannabis Capital Conference taking place September 27 through 28. In this episode of the Trade To Black podcast, we are sitting down with Elliot Lane, the Host & Corporate Partnerships Manager at Benzinga.

Sen. Cory Booker, Signs On As Co-Sponsor To SAFER Banking Act

Sen. Cory Booker, Signs On As Co-Sponsor To SAFER Banking Act

On Wednesday, the Senate introduced a revamped cannabis banking bill featuring an updated title and several fresh provisions pertaining to federal financial regulations, guidance, and reporting requirements. This time, a familiar foe has come on board to support the next iteration of regulated cannabis banking—the SAFER Banking Act.

House Financial Services Committee Debates, Passes CBDC Anti-Surveillance State Act

House Financial Services Committee Debates, Passes CBDC Anti-Surveillance State Act

During the deliberation of the CBDC Anti-Surveillance State Act (H.R. 5403) in the US House of Representatives Financial Services Committee on September 20. The bill sought to address the critical issues surrounding central bank digital currencies (CBDCs), such as the privacy of American citizens and the role of government in daily life.